Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Grisouard, Jean ^a   Dembinski, Kaethi ^a   Mayer, Doris ^b   Keller, Ulrich ^a   Müller, Beat ^c   Christ Crain, Mirjam ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER   (Germany)

^c Medical University Clinic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; METFORMIN; SMALL INTERFERING RNA;

ADIPOCYTE; ADULT; ARTICLE; BIOPSY; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; LOW GRADE INFLAMMATION; MALE; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; RNA ANALYSIS; RNA EXTRACTION;

EID: 79960556096     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-16     Document Type: Article

References (30)

1. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M, Lancet 2005 366 1784 1793 10.1016/S0140-6736(05)67725-2 16298215 (Pubitemid 41642642)
2. Obesity and prognosis of breast cancer. Carmichael AR, Obes Rev 2006 7 333 340 10.1111/j.1467-789X.2006.00261.x 17038127 (Pubitemid 44564304)
3. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS, Jama 2003 289 76 79 10.1001/jama.289.1.76 12503980 (Pubitemid 36026281)
4. Diabetes mellitus and risk of breast cancer: a meta-analysis. Larsson SC, Mantzoros CS, Wolk A, International journal of cancer 2007 121 856 862 10.1002/ijc.22717 (Pubitemid 47106217)
5. Diabetes and cancer. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R, Endocr Relat Cancer 2009 16 1103 1123 10.1677/ERC-09-0087 19620249
6. Obesity and overweight/Diabetes/Breast cancer. http://www.who.int/
7. Adipose tissue as an endocrine organ. Kershaw EE, Flier JS, J Clin Endocrinol Metab 2004 89 2548 2556 10.1210/jc.2004-0395 15181022 (Pubitemid 38766330)
8. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Calle EE, Kaaks R, Nat Rev Cancer 2004 4 579 591 10.1038/nrc1408 15286738 (Pubitemid 39025053)
9. Molecular links between obesity and breast cancer. Lorincz AM, Sukumar S, Endocr Relat Cancer 2006 13 279 292 10.1677/erc.1.00729 16728564 (Pubitemid 43886659)
10. Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives. Maccio A, Madeddu C, Mantovani G, Obes Rev 2009 10 660 670 10.1111/j.1467-789X.2009.00592.x 19460113
11. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Shukla A, Grisouard J, Ehemann V, Hermani A, Enzmann H, Mayer D, Endocr Relat Cancer 2009 16 429 441 10.1677/ERC-08-0240 19153208
12. Inflammation, stress, and diabetes. Wellen KE, Hotamisligil GS, J Clin Invest 2005 115 1111 1119 15864338 (Pubitemid 40629025)
13. High-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Erridge C, Attina T, Spickett CM, Webb DJ A, Am J Clin Nutr 2007 86 1286 1292 17991637 (Pubitemid 350126229)
14. Metabolic endotoxemia initiates obesity and insulin resistance. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R, Diabetes 2007 56 1761 1772 10.2337/db06-1491 17456850 (Pubitemid 47025442)
15. Metformin, the gold standard in type 2 diabetes: what does the evidence tell us? Bosi E, Diabetes Obes Metab 2009 11 Suppl 2 3 8 19385978
16. Functions of AMP-activated protein kinase in adipose tissue. Daval M, Foufelle F, Ferre P, J Physiol 2006 574 55 62 10.1113/jphysiol.2006.111484 16709632 (Pubitemid 43905796)
17. Both inflammatory and classical lipolytic pathways are involved in lipopolysaccharides (LPS)-induced lipolysis in human adipocytes. Grisouard J, Bouillet E, Timper K, Radimerski T, Dembinski K, Frey DM, Peterli R, Zulewski H, Keller U, Müller B, Christ-Crain1 M, Innate Immunity 2010
18. Mechanisms of metformin action on glucose transport and metabolism in human adipocytes. Grisouard J, Timper K, Radimerski TM, Dembinski K, Frey DM, Kola B, Korbonits M, Herrmann P, Krähenbühl S, Zulewski H, Keller U, Müller B, Christ-Crain M, Biochem Pharmacol 2010 80 1736 1745 10.1016/j.bcp.2010.08.021 20816671
19. Autocrine/paracrine role of inflammation-mediated Calcitonin Gene-Related Peptide and Adrenomedullin expression in human adipose tissue. Linscheid P, Seboek D, Zulewski H, Keller U, Muller B, Endocrinology 2005 146 2699 708 10.1210/en.2004-1424 15761041 (Pubitemid 40695573)
20. AMP-activated protein kinase mediates glucocorticoid induced metabolic changes: a novel mechanism in Cushing's syndrome. Christ-Crain M, Kola B, Lolli F, Fekete C, Seboek D, Wittmann G, Feltrin D, Igreja SC, Ajodha S, Harvey-White J, Kunos G, Muller B, Pralong F, Aubert G, Arnaldi G, Giacchetti G, Boscaro M, Grossman AB, Korbonits M, Faseb J 2008 22 1672 1683 10.1096/fj.07-094144 18198220 (Pubitemid 351811445)
21. Decreased AMP-activated protein kinase activity is associated with markers of inflammation and infiltration of immune cells in visceral and subcutaneous adipose tissue, and with whole-body insulin resistance in obese patients [abstract]. Gauthier MS, Mott M, Gokce N, Apovian C, Ruderman NB, Obesity 2009 17 93
22. Control of breast cancer cell growth by adipocyte-released factors. D'Esposito V, [PhD Thesis] 2009
23. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A, Szymczak J, Bednarek-Tupikowska G, Demissie M, Gynecological Endocrinol 2008 24 378 384 10.1080/09513590802128968 (Pubitemid 352032225)
24. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients. Derosa G, Maffiolia P, Salvadeoa SAT, Ferraria I, Ragonesib PD, Quercic F, Franzettid IG, Gadaletae G, Ciccarellif L, Piccinnig MN, D'Angeloa A, Ciceroh AFG, Metabolism 2010 59 887 895 10.1016/j.metabol.2009.10.007 20015525
25. Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations-introductory report. Marciniak A, Nawrocka-Rutkowska J, Brodowska A, Sienkiewicz R, Szydlowska I, Starczewski A, Folia Histochemica et Cytobiologica 2009 47 323 328 10.2478/v10042-009-0032-0 19995720
26. Metformin inhibits TNF - induced IB kinase phosphorylation, IB- degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ, Lai LP, Int J Cardiol 2009 134 169 175 10.1016/j.ijcard.2008.04.010 18597869
27. Adiponectin and AdipoR1 regulate PGC-1a and mitochondria by Ca2+ andAMPK/SIRT1. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata1 M, Yamaguchi1 M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota1 N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T, Nature 2010 464 1313 1319 10.1038/nature08991 20357764
28. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK, Sharma D, Oncogene 2009 28 2621 2633 10.1038/onc.2009.129 19483724
29. Insulin and insulin-like growth factor signalling in neoplasia. Pollak M, Nature Rev Cancer 2008 8 915 928 10.1038/nrc2536
30. AMPK as a mediator of hormonal signalling. Lim CT, Kola B, Korbonits M, J Mol Endocrinol 2010 44 87 97 10.1677/JME-09-0063 19625456